NCT02531672No Longer Available不适用
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography: An Expanded Access Study
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 5
研究概览
简要总结
The purpose of this study is to use a new imaging drug called 11C-choline that is used with a PET/CT scan to see prostate cancer when it cannot be seen well on other scans, such as bone scans, CT or MRI.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Patient must have biopsy-proven adenocarcinoma of the prostate initially treated with curative intent (surgery and radiation therapy are most common treatments but other treatments are also eligible).
- •Biochemical recurrence defined as any of the following:
- •PSA ≥ 0.2 ng/mL in at least two sequential tests for patients treated with surgery.
- •PSA ≥ 0.2 ng/mL above the post therapy nadir for patients treated with radiation therapy, brachytherapy or cryotherapy.
- •PSA ≥ 0.2 ng/ml above the most recent therapy nadir for patients who have received additional treatment in the recurrent setting
- •Patient must have undergone standard-of-care restaging that does not clearly identify site(s) of active disease, or such prior studies must show equivocal findings for which further work-up is considered necessary to make clinical decision. Standard staging examinations may include one or more of the following: CT or MRI, bone imaging (either Tc-99m bisphosphonate scintigraphy MDP or F-18 sodium fluoride PET), FDG PET, or In-111 capromab pendetide scintigraphy no older than 3 months of consent date.
- •Age ≥ 18 years.
- •Patient must be able to tolerate PET/CT imaging.
- •Patient must be able to understand and willing to sign a written informed consent document.
排除标准
- •Patient must not have claustrophobia that would preclude PET/CT imaging or other contraindications to CT imaging.
研究者
研究点 (5)
Loading locations...
相似试验
Approved For Marketing
不适用
Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access StudyCancer of the ProstateNCT02355054Washington University School of Medicine
已完成
1 期
C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate CancerProstate CancerNCT00804245Wake Forest University Health Sciences18
No Longer Available
不适用
C11 Sodium Acetate PET/CT Imaging of PCaProstate CancerNCT02826395Jonsson Comprehensive Cancer Center
已完成
1 期
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate CancerProstate CancerNCT00924313National Cancer Institute (NCI)40
已完成
不适用
Diagnosis of prostate cancer by carbon 11-choline positron emission tomography/computed tomographyProstate cancerJPRN-UMIN000029750ational center for global health and medicine50